跳至主要内容
临床试验/NCT00724633
NCT00724633已完成3 期

Effect of Lowering the Dialysate Sodium on Blood Pressure in Hemodialysis Patients: a Randomized Controlled Trial.

Lawson Health Research Institute2 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2011年11月1日最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
已完成
入组人数
35
试验地点
2
主要终点
Ambulatory blood pressure

研究概览

简要总结

Patients currently receiving hemodialysis will be randomized to receive 1 of 3 dialysate sodium prescriptions. The effects on blood pressure, interdialytic weight gain, thirst, and intradialytic symptoms will be assessed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients on 3 times weekly hemodialysis of at least 3 months
  • elevated average ambulatory blood pressures
  • current dialysate sodium prescription 140mEq/L
  • average pre-dialysis serum sodium <140mEq/L

排除标准

  • frequent intradialytic hypotension
  • estimated life expectancy <1 year
  • non-adherence to dialysis prescription
  • pregnancy
  • inability or unwillingness to complete study measures

研究组 & 干预措施

1

Other

standard dialysate Na 140 mEq/L

干预措施: Lowering the dialysate sodium (Other)

2

Active Comparator

dialysate sodium equal to patient's predialysis serum Na

干预措施: Lowering the dialysate sodium (Other)

3

Active Comparator

dialysate sodium lower than patient's predialysis plasma sodium

干预措施: Lowering the dialysate sodium (Other)

结局指标

主要结局

Ambulatory blood pressure

时间窗: 3 months

Ambulatory blood pressure to be taken over 24 hours at 4 week intervals throughout the study

次要结局

  • intradialytic hypotension rate, intradialytic symptoms(3 months)
  • QOL Scores (KDQOL, mins to recovery)(3 months)
  • thirst(3 months)
  • mechanistic outcomes: interdialytic weight gain, extracellular fluid water, sodium ionic mass balance(3 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验